Montreal, Canada – October 30, 2012 – Theratechnologies Inc. (TSX: TH) (NASDAQ: THER) today announced its revised business plan which will focus on revenue growth from tesamorelin in the short term ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback